Viewing StudyNCT06446154



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06446154
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-06
First Post: 2024-05-30

Brief Title: FOLFOX Chemotherapy Plus Fruquintinib and Sintilimab After First-line Treatment in Unresectable Hepatocellular Carcinoma
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Hepatocellular Carcinoma
Immunotherapy
Anti-angiogenic Therapy
FOLFOX Systemic Chemotherapy
Second-line Treatment
Keywords: